A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis
Clinical trial NCT03976648 · TERMINATED
Trial details
- NCT number
- NCT03976648
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-18
- Primary completion
- 2021-04-13
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.